Picture of Nutex Befektetesi Nyrt logo

NUTEX Nutex Befektetesi Nyrt Income Statement

0.000.00%
hu flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual income statement for Nutex Befektetesi Nyrt, fiscal year end - December 31st, HUF millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue4.130.750.450.450.45
Cost of Revenue
Gross Profit4.130.75
Selling / General / Administrative Expenses
Other Operating Expenses
Total Operating Expenses13.510.21813.616.4
Operating Profit-9.4-9.49-17.6-13.1-16
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes-389-7.7227.313.3139
Provision for Income Taxes
Net Income After Taxes-376-8.0126.112.7134
Net Income Before Extraordinary Items
Net Income-376-8.0126.112.7134
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-376-8.0126.112.7134
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-28.4-0.2160.3650.0860.902
Dividends per Share